Cochlear implantation in child.
Implants in children of the Nucleus 22-channel system have recently been approved in the United States by the Food and Drug Administration (FDA). Several questions still remains, however, concerning patient selection. This paper presents a statistical method of reporting results and its application to two populations of cochlear implant candidates: congenitally deaf children, and profoundly deaf children with meningitis as the cause of their deafness. It has been suggested that as these two groups may have significantly lower performance than other populations, it may not be appropriate to select them as implant candidates. The statistical method used aggregated single-subject, repeated measures data to reach conclusions on performance. Findings for congenitally deaf subjects evidenced significant improvements over preoperative performance. Results for post-meningitic children showed no significant difference in overall performance compared to non-meningitic children.